Offer - Urjas Oil for just ₹ 1
Sensonac 0.01% Injection is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
Is the use of Sensonac 0.01% Injection safe for pregnant women?
Sensonac can have harmful effects in pregnant women. If you experience any discomfort after using Sensonac, then discontinue the use and take your doctor's advice.
Is the use of Sensonac 0.01% Injection safe during breastfeeding?
In the absence of any scientific study about the side effects of Sensonac in breastfeeding women, information on safety of Sensonac is unavailable.
What is the effect of Sensonac 0.01% Injection on the Kidneys?
Sensonac is not harmful for kidneys.
What is the effect of Sensonac 0.01% Injection on the Liver?
Sensonac is completely safe for the liver.
What is the effect of Sensonac 0.01% Injection on the Heart?
Sensonac is rarely harmful for the heart.
If you are suffering from any of the following diseases, you should not take Sensonac 0.01% Injection unless your doctor advises you to do so -
Is this Sensonac 0.01% Injection habit forming or addictive?
No, there is no any evidence that Sensonac 0.01% Injection is addictive.
Is it safe to drive or operate heavy machinery when consuming?
Yes, you can operate a vehicle or heavy machinery after taking Sensonac 0.01% Injection since it does not cause drowsiness.
Is it safe?
Sensonac 0.01% Injection is safe as it does not bear any side effects.
Is it able to treat mental disorders?
No, the use of Sensonac 0.01% Injection in mental disorders is not effective.
Interaction between Food and Sensonac 0.01% Injection
You can take Sensonac 0.01% Injection with food.
Interaction between Alcohol and Sensonac 0.01% Injection
Information about the interaction of Sensonac 0.01% Injection and alcohol is not currently available because this topic has not been researched yet.
This medicine data has been created by -
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1404
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Nevanac® (nepafenac)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Ilevro® (nepafenac)
